Exosome-functionalized alginate/gelatin composite scaffolds: synergistic enhancement of osteogenic differentiation for bone tissue engineering.
Meskaraf-Asadabadi M., Khazaei MR., Amiri M., Ghesmati Z., Ghanbari E.
Laboratory Study, published in J Orthop Surg Res (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- J Orthop Surg Res (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42163379
- DOI
- 10.1186/s13018-026-06945-7
Abstract (original English)
This study investigates the osteogenic potential of exosome (Exo)-loaded alginate/gelatin (OA/Gel) macromolecular composite scaffolds for human adipose-derived stem cells (hASCs). OA/Gel scaffolds were fabricated and crosslinked with EDC, followed by the incorporation of Exo at concentrations of 0.5, 1, 2, and 4 µL. The scaffolds were characterized in terms of morphology, porosity, swelling behavior, mechanical properties, and cell adhesion. Osteogenic differentiation was assessed through alkaline phosphatase activity, Alizarin Red staining, and RT-PCR for Runt-related transcription factor 2, alkaline phosphatase, and bone gamma-carboxyglutamic acid-containing protein expression. Scanning electron microscopy analysis revealed interconnected pores predominantly within the range of 100-200 μm, with OA/Gel scaffolds demonstrating reduced pore size and enhanced mechanical strength compared to single-component scaffolds. The OA/Gel macromolecular scaffold exhibited optimal pore architecture (~ 180 μm), superior cell adhesion and proliferation, and significantly upregulated osteogenic markers at days 7 and 21. These findings suggest that Exo-loaded OA/Gel scaffolds, particularly at a concentration of 2.0 µL Exo, provide a favorable three-dimensional microenvironment for hASC osteogenic differentiation, highlighting their potential as a promising biomaterials for bone tissue engineeri
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.